Garvan and Roche to collaborate on epigenomic analysis
25 August, 2014Roche Sequencing and the Garvan Institute of Medical Research have announced a collaboration to develop new technologies for targeted epigenomic analysis using DNA sequencing.
New EMBL Australia node
21 August, 2014A partnership between the University of New South Wales and the European Molecular Biology Laboratory will set up a new EMBL Australia node.
Abcam establishes a direct service for ANZ
20 August, 2014Protein research tool provider Abcam has established a direct service to Australia and New Zealand.
Personalised, predictive, preventive and participatory
20 August, 2014The upcoming Annual Scientific Conference of the Australasian Association of Clinical Biochemists (AACB) will focus on Clinical Biochemistry Supporting P4 Medicine - the four 'Ps' representing personalised, predictive, preventive and participatory.
Finding markers for inflammation and auto-immunity
06 August, 2014 by Graeme O'NeillProfessor Mark Hogarth has spent most of his career studying the role of Fc receptors in inflammatory and auto-immune disorders. Found on the surface of a variety of immune cells, these antibody-binding receptors are now prospective targets for new treatments of inflammation, therapeutic monoclonal antibodies in cancer and manipulation in vaccines for HIV-AIDS.
QFAB, Garvan team for genome sequence analysis
04 August, 2014 by Dylan Bushell-EmblingQFAB Bioinformatics and the Garvan Institute of Medical Research will combine their capabilities to offer human genome sequence data analysis for scientists and clinicians.
Jeans for Genes Day toolkit
01 August, 2014This year's Jeans for Genes Day marks the 21st year of a campaign that provides much-needed support for research, such as the development of a pharmacological toolkit for researchers.
Suppressing tumour growth via telomerase
18 July, 2014 by Susan WilliamsonSimultaneously inhibiting the expression of another gene makes targeting telomerase much more effective in suppressing tumour growth.
Public sector driving personalised medicine research
24 June, 2014 by Dylan Bushell-EmblingPublic research bodies are responsible for the largest share of patent applications related to personalised medicine internationally, Marks & Clerk research shows.
Algae share insights into quantum biology
19 June, 2014Algae that survive in environments with very low light use quantum mechanics to change the shape of a protein during photosynthesis and proposedly improve their energy uptake.
Telomeres need to last a lifetime
19 June, 2014 by Susan WilliamsonWorld leaders in telomere research recently gathered in Sydney for the Short Telomere Syndrome Conference to share knowledge and work towards forming an international consortium to progress the understanding of telomeres and associated diseases.
Getting personal with cancer
18 June, 2014 by Tim DeanRecent work on developing targeted treatments for pancreatic cancer is paving the way for new approaches in personalised medicine.
Eucalyptus genome sequenced
13 June, 2014Initial results of the Eucalyptus genome sequence have been revealed.
Genetic Technologies hires new CFO
11 June, 2014Genetic Technologies' (ASX:GTG) new CFO, Eutillio Buccilli, has more than 35 years of senior management experience.
Reconfiguring the link between GAD65 and diabetes
11 June, 2014Another step has been taken in understanding the link between glutamic acid decarboxylase and type 1 diabetes.
